Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-004187
Filing Date
2009-04-15
Accepted
2009-04-15 17:12:47
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2192324z10-k.htm 10-K 596324
2 EXHIBIT 10.4 a2192324zex-10_4.htm EX-10.4 95992
3 EXHIBIT 10.5 a2192324zex-10_5.htm EX-10.5 123752
4 EXHIBIT 14 a2192324zex-14.htm EX-14 21575
5 EXHIBIT 21 a2192324zex-21.htm EX-21 1564
6 EXHIBIT 31.1 a2192324zex-31_1.htm EX-31.1 7982
7 EXHIBIT 31.2 a2192324zex-31_2.htm EX-31.2 8002
8 EXHIBIT 32.1 a2192324zex-32_1.htm EX-32.1 4486
9 EXHIBIT 32.2 a2192324zex-32_2.htm EX-32.2 4494
  Complete submission text file 0001047469-09-004187.txt   865705
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
Synergy Pharmaceuticals, Inc. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-131722 | Film No.: 09751878
SIC: 5990 Retail-Retail Stores, NEC